RABT Global provides expert Pharmaceutical Regulatory Service Support in ASEAN countries designed to navigate the evolving and harmonizing pharmaceutical regulatory landscape in Southeast Asia for seamless market access and compliance.
Pharmaceutical Regulatory Support Services in ASEAN
Regulatory Strategy & Gap Analysis
Develop tailored, country-specific regulatory strategies aligned with the ASEAN Pharmaceutical Regulatory Framework (APRF) and national regulations. Identify and address gaps early for efficient submissions and lifecycle management.Dossier Preparation & Submission Support
Compile, review, and manage high-quality pharmaceutical dossiers following the ASEAN common technical requirements and local health authority expectations. Facilitate timely submissions and effective communication with national agencies such as Thailand FDA, Malaysia’s NPRA, Singapore HSA, Indonesia BPOM, and others.Local Regulatory Representation & Legal Agent Services
Act as your authorized local representative in ASEAN countries to ensure smooth regulatory correspondence and compliance maintenance.Compliance & Quality Consulting
Guide adherence to Good Manufacturing Practice (GMP), Good Clinical Practice (GCP), and ASEAN harmonized regulatory standards. Support audits, internal controls, and post-approval activities.Pharmacovigilance & Safety Monitoring
Establish and maintain pharmacovigilance systems compliant with ASEAN regulations for adverse event reporting and risk management throughout the drug lifecycle.Market Access & Reimbursement Advisory
Provide insights and strategies to navigate reimbursement schemes and accelerate competitive market access in diverse ASEAN healthcare systems.
Why Choose RABT Global for ASEAN Pharmaceutical Regulatory Services?
ASEAN Regulatory Expertise: Deep understanding of the newly adopted ASEAN Pharmaceutical Regulatory Framework (APRF) which promotes harmonization, collaboration among national regulatory authorities, and a common approach to pharmaceutical product lifecycle regulation.
End-to-End Support: From strategic planning and dossier management to local representation and post-market compliance, RABT Global covers every regulatory aspect needed for ASEAN markets.
Efficiency & Compliance: Streamline regulatory approvals with compliance to ASEAN and member states’ evolving standards aimed at ensuring timely access to safe, efficacious, and quality pharmaceuticals.
Trusted Regional Partner: Experienced working with ASEAN national agencies and familiar with the regulatory environment, enabling reduced time to market and minimized compliance risks.
Contact RABT Global today to ensure your pharmaceutical products achieve robust regulatory clearance and sustained success across the ASEAN region, leveraging expert guidance aligned with ASEAN’s integrated and harmonized pharmaceutical regulatory policies and frameworks.
This content reflects the ongoing development and implementation of the ASEAN Pharmaceutical Regulatory Framework (APRF), adopted in 2023, which guides harmonized pharmaceutical regulation across ASEAN member states.
